喉鳞状细胞癌组织中碳酸酐酶9与P糖蛋白的表达和临床意义

陈歆维, 王菲, 谢芳, 等. 喉鳞状细胞癌组织中碳酸酐酶9与P糖蛋白的表达和临床意义[J]. 临床耳鼻咽喉头颈外科杂志, 2016, 30(1): 42-44. doi: 10.13201/j.issn.1001-1781.2016.01.012
引用本文: 陈歆维, 王菲, 谢芳, 等. 喉鳞状细胞癌组织中碳酸酐酶9与P糖蛋白的表达和临床意义[J]. 临床耳鼻咽喉头颈外科杂志, 2016, 30(1): 42-44. doi: 10.13201/j.issn.1001-1781.2016.01.012
CHEN Xinwei, WANG Fei, XIE Fang, et al. Expression and clinical pathological implications of carbonic anhydrase 9 and P glycoprotein in laryngeal squamous cell carcinoma[J]. J Clin Otorhinolaryngol Head Neck Surg, 2016, 30(1): 42-44. doi: 10.13201/j.issn.1001-1781.2016.01.012
Citation: CHEN Xinwei, WANG Fei, XIE Fang, et al. Expression and clinical pathological implications of carbonic anhydrase 9 and P glycoprotein in laryngeal squamous cell carcinoma[J]. J Clin Otorhinolaryngol Head Neck Surg, 2016, 30(1): 42-44. doi: 10.13201/j.issn.1001-1781.2016.01.012

喉鳞状细胞癌组织中碳酸酐酶9与P糖蛋白的表达和临床意义

  • 基金项目:

    上海市自然科学基金面上项目(No:13ZR1433600)

详细信息
    通讯作者: 董频,E-mail:dongpin64@aliyun.com
  • 中图分类号: R739.6

Expression and clinical pathological implications of carbonic anhydrase 9 and P glycoprotein in laryngeal squamous cell carcinoma

More Information
  • 目的:研究喉鳞状细胞癌与喉良性病变组织中碳酸酐酶9(CA Ⅸ)和P糖蛋白(P-gp)表达的差异,分析2种蛋白在喉鳞状细胞癌组织中表达的相关性,及两者与喉鳞状细胞癌临床病理特征的关系。方法:采用免疫组织化学EnVision二步法分别检测47例喉鳞状细胞癌组织、20例声带息肉组织中CA Ⅸ和P-gp的表达情况。结果:CA Ⅸ和P-gp在喉鳞状细胞癌组织中的阳性表达率和它们在声带息肉中的表达均差异有统计学意义(P<0.05),且两者在喉鳞状细胞癌组织中的表达呈正相关(r=0.324,P<0.05)。CA Ⅸ蛋白表达与喉鳞状细胞癌的临床分期、淋巴结转移有关(P<0.05);与喉鳞状细胞癌组织学分级、原发部位无关(P>0.05)。P-gp表达与喉鳞状细胞癌的临床分期、组织学分级有关(P<0.05);与喉鳞状细胞癌的原发部位、淋巴结转移无关(P>0.05)。结论:CA Ⅸ与P-gp的高表达可能在喉鳞状细胞癌的病情进展中起一定作用。
  • 加载中
  • [1]

    PEREZ-GUTIERREZ S,GONZALEZ-CAMPORA R,AMERIGO-NAVARRO J,et al.Expression of Pglycoprotein and metallothionein in gastrointestinal stromaltumor and leiomyosarcomas.Clinical implications[J].Pathol Oncol Res,2007,13:203-208.

    [2]

    XIE J,LI D W,CHEN X W,et al.Expression and significance of hypoxia-inducible factor-1αand MDR1/P-glycoprotein in laryngeal carcinoma tissue and hypoxic Hep-2cells[J].Oncol Lett,2013,6:232-238.

    [3]

    李大伟,高尚,陈歆维,等.缺氧诱导因子-1α与P糖蛋白在LSCC中的表达及临床意义[J].山东大学耳鼻喉眼学报,2010,24(1):6-9.

    [4]

    SASSO E,VITALE M,MONTELEONE F,et al.Bindingof carbonic anhydraseⅨto 45S rDNA genes is prevented by exportin-1in hypoxic cells[J].Biomed Res Int,2015,2015:674-692.

    [5]

    ILARDI G,ZAMBRANO N,MEROLLA F,et al.Histopathological determinants of tumor resistance:aspecial look to the immunohistochemical expression of carbonic anhydraseⅨinhuman cancers[J].Curr Med Chem,2014,21:1569-1582.

    [6]

    BUANNE P,RENZONE G,MONTELEONE F,et al.Characterization of carbonicanhydraseⅨinteractome reveals proteins assisting its nuclear localization inhypoxic cells[J].J Proteome Res,2013,12:282-292.

    [7]

    BROCKTON N,DORT J,LAU H,et al.High stromal carbonic anhydraseⅨexpression is associated with decreased survival in P16-negative head-and-neck tumors[J].Int J Radiat Oncol Biol Phys,2011,80:249-257.

    [8]

    LI L,JIANG A C,DONG P,et al.The characteristics of Hep-2cell withmultiple drug resistance induced by Taxol[J].Otolaryngol Head Neck Surg,2007,137:659-664.

  • 加载中
计量
  • 文章访问数:  35
  • PDF下载数:  27
  • 施引文献:  0
出版历程
收稿日期:  2015-06-15

目录